Environmental risk factors in the development of adenocarcinoma of the oesophagus or gastric cardia: A cross-sectional study in a Dutch cohort

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 1, 2007, Pages 31-39

  De Jonge, P J F ^a   Wolters, L M M ^a   Steyerberg, E W ^a   Van Dekken, H ^a   Kusters, J G ^a   Kuipers, E J ^a   Siersema, P D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY POSTURE; CANCER RISK; CARDIA; CARDIA CARCINOMA; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; ENVIRONMENTAL EXPOSURE; ESOPHAGEAL ADENOCARCINOMA; FAMILY HISTORY; FEMALE; FRUIT; GASTROESOPHAGEAL REFLUX; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OCCUPATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; SMOKING; SQUAMOUS CELL CARCINOMA; SYMPTOMATOLOGY; VEGETABLE;

ADENOCARCINOMA; AGED; ALCOHOL DRINKING; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIET; ENVIRONMENT; ESOPHAGEAL NEOPLASMS; EXERCISE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; STOMACH NEOPLASMS;

EID: 34250195791     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03344.x     Document Type: Article

References (29)

1. Devesa SS, Blot WJ, Fraumeni JF, Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998 83 : 2049 53.
2. El-Serag HB, Mason AC, Petersen N, et al. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002 50 : 368 72.
3. van Blankenstein M, Looman C, Siersema PD, et al. Differential time trends in the incidence of cancer of the esophagus in the Netherlands 1989-2001. Gastroenterology 2006 30 (Suppl. 2 S1103.
4. Vaughan TL, Davis S, Kristal A, et al. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995 4 : 85 92.
5. Pera M, Manterola C, Vidal O, et al. Epidemiology of esophageal adenocarcinoma. J Surg Oncol 2005 92 : 151 9.
6. Wijnhoven BP, Siersema PD, Hop WC, et al. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity Rotterdam Oesophageal Tumour Study Group. Br J Surg 1999 86 : 529 35.
7. Driessen A, van Raemdonck D, De Leyn P, et al. Are carcinomas of the cardia oesophageal or gastric adenocarcinomas? Eur J Cancer 2003 39 : 2487 94.
8. DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol 2006 13 : 12 30.
9. Westerterp M, Koppert LB, Buskens CJ, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005 446 : 497 504.
10. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998 85 : 1457 9.
11. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002 97 : 1888 95.
12. de Jonge PJ, Steyerberg EW, Kuipers EJ, et al. Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol 2006 101 : 1421 9.
13. Dolan K, Sutton R, Walker SJ, et al. New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer 1999 80 : 834 42.
14. Kubo A, Corley DA. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer 2002 95 : 2096 102.
15. Marsman WA, Tytgat GN, ten Kate FJ, et al. Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction. J Surg Oncol 2005 92 : 160 8.
16. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999 340 : 825 31.
17. Chak A, Faulx A, Eng C, et al. Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia. Cancer 2006 107 : 2160 6.
18. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999 130 : 883 90.
19. Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998 90 : 150 5.
20. Lagergren J. Controversies surrounding body mass, reflux, and risk of oesophageal adenocarcinoma. Lancet Oncol 2006 7 : 347 9.
21. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986 315 : 362 71.
22. Akre K, Ekstrom AM, Signorello LB, et al. Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. Br J Cancer 2001 84 : 965 8.
23. Vaughan TL, Dong LM, Blount PL, et al. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol 2005 6 : 945 52.
24. Mehta S, Johnson IT, Rhodes M. Systematic review: the chemoprevention of oesophageal adenocarcinoma. Aliment Pharmacol Ther 2005 22 : 759 68.
25. Souza RF, Shewmake K, Beer DG, et al. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res 2000 60 : 5767 72.
26. Buttar NS, Wang KK, Anderson MA, et al. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study. J Natl Cancer Inst 2002 94 : 422 9.
27. Kaur BS, Khamnehei N, Iravani M, et al. Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus. Gastroenterology 2002 123 : 60 7.
28. Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003 95 : 1404 13.
29. Mayne ST, Risch HA, Dubrow R, et al. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 2001 10 : 1055 62.